Background: The Arterial Revascularization Trial has been designed to answer the question whether the use of bilateral internal thoracic arteries can improve 10-year outcomes when compared with single internal thoracic arteries. In the Arterial Revascularization Trial, a significant proportion of patients initially allocated to bilateral internal thoracic arteries received other conduit strategies. We sought to investigate the incidence and clinical implication of bilateral internal thoracic artery graft conversion in the Arterial Revascularization Trial.
Although large observational studies have consistently suggested that the use of bilateral internal thoracic artery (BITA) grafting improves long-term survival when compared with single internal thoracic artery (SITA) grafting in coronary artery bypass grafting (CABG), 1,2 the use of BITA grafting remains particularly low. BITA grafting represents only 4% to 12% of all CABG procedures over the more traditional use of the SITA with additional saphenous vein grafts (SVGs). 3 The reasons for BITA underuse are multifactorial. Most surgeons do not perform BITA grafting because of the increased risk of sternal wound complications and technical complexity. 4, 5 However, some patients initially intended to receive BITA grafts require intraoperative conversion to other conduit strategies. The incidence and causes of intraoperative BITA graft conversion and its clinical implication have never been investigated.
The Arterial Revascularization Trial (ART) has been designed to answer the question whether the use of BITAs can improve 10-year outcomes when compared with SITAs in CABG. 6 Interim 5-year results have shown similar clinical outcomes between the 2 groups. 7 In the ART, only surgeons with experience of 50 or more BITA operations were able to undertake BITA procedures in the trial. 6 We sought to investigate the reasons for intraoperative BITA graft conversion and its clinical implication by performing a post hoc analysis of the ART.
MATERIALS AND METHODS
A post hoc analysis of 5-year outcomes of the ART was conducted. This research adheres to the principles set forth in the Declaration of Helsinki (http://www.wma.net/en/30publications/10policies/b3/index.html). Among patients enrolled in the ART (n ¼ 3102) from 2004 to 2007, we excluded those allocated to SITA (n ¼ 1554), those who did not undergo surgery (n ¼ 16), and those who underwent operation but withdrew after randomization (n ¼ 7).
Trial Design
The ART was approved by the institutional review board of all participating centers, and informed consent was obtained from each participant. The protocol for the ART has been published. 6 Briefly, the ART is a 2-arm, randomized multicenter trial conducted in 28 hospitals in 7 countries (Appendix 1), with patients being randomized equally to SITA or BITA grafts. Eligible patients were those with multivessel coronary artery disease undergoing CABG. BITA graft configuration (y graft vs in situ graft vs free graft) was left at the discretion of the surgeon (Video 1). Patients requiring single grafts or redo CABG were excluded. Patients with evolving myocardial infarction (MI) (defined as the increase and decrease of a biomarker together with one of a longer list of criteria comprising ischemic symptoms, the development of pathologic Q waves, ischemic electrocardiographic changes, and a coronary artery intervention) were also excluded. However, patients with unstable angina defined as pain on any activity or rest pain were included.
Follow-up
Questionnaires were sent to study participants by mail every year after surgery. No clinic visits were planned apart from the routine clinical 6-week postoperative visit. Participants were sent stamped addressed envelopes to improve the return rates of postal questionnaires. Study coordinators contacted participants by telephone to alert them to the questionnaire's arrival and to ask them about medications, adverse events, and health services resource use. Five-year follow-up was completed for all patients included in the present analysis.
Study Outcomes
Hospital outcomes investigated were reexploration for bleeding, intraaortic balloon pump (IABP) insertion, MI, cerebrovascular accident (CVA), postoperative atrial fibrillation, sternal complications VIDEO 
Outcome Definitions
Death was classified into cardiovascular and noncardiovascular, where possible, using autopsy reports and death certificates. Congestive heart failure, arrhythmia, MI, pulmonary embolus, and dissection were considered cardiovascular causes of death.
MI was diagnosed when 2 of the following 3 criteria were present: (1) unequivocal electrocardiogram changes; (2) elevation of cardiac enzyme(s) above twice the upper limit of normal or diagnostic troponin increases; or (3) chest pain typical for acute MI that lasted more than 20 minutes. CVA was defined as a new neurologic deficit evidenced by clinical signs of paresis, plegia, or new cognitive dysfunction including any mental status alteration lasting more than 24 hours or evidence on computed tomography or MRI scan of recent brain infarct (<6 months). Repeat revascularization was defined as coronary bypass surgery or percutaneous coronary intervention performed after the trial procedure. Sternal complications included sternal wound infection requiring antibiotics, vacuum-assisted closure therapy, debridement, or reconstruction.
Statistical Analysis
Multiple imputation (m ¼ 3) was used to address missing data. Rubin's method 8 was used to combine results from each of the imputed data sets (Amelia R package). Because of the lack of randomization with regard to BITA conversion, a propensity score (PS) was generated for each patient from a multivariable logistic regression model (C-statistics 0.64) based on a prespecified set of covariates (as listed in Table 1 ) with requiring conversion versus nonconverted as a binary dependent variable. 9 Pairs of patients were derived using greedy 1:3 matching with a caliper of width of 0.2 standard deviation of the logit of the PS (nonrandom R package). The quality of the match was assessed by comparing selected pretreatment variables in PSmatched patients using the standardized mean difference, with an absolute standardized difference of greater than 10% taken to represent meaningful covariate imbalance. 9 McNemar's test and paired t test were used to assess the statistical significance of the risk difference for hospital outcomes, and stratified log-rank was used to assess the statistical significance of the risk difference for mortality and MACCE at 5 years. A risk-competing framework was used to estimate the treatment effect on MACCE individual components (survival R package and riskRegression R package).
RESULTS

Study Population
A total of 1525 patients were operated with intention to receive BITA grafting. Of those, 233 (15.3%) were converted to other conduit selection strategies. Incidence of conversion largely varied across 131 participating surgeons ( Figure 1 and Table E1 ). The most common reason for BITA grafts conversion was the evidence of at least 1 internal thoracic artery (ITA) that was not suitable, which was reported in 77 cases (33.0%). This was due to damage during harvesting (n ¼ 41), poor flow without apparent injury (n ¼ 23), and conduit too short for grafting (n ¼ 13). The second most common reasons for BITA conversion were poor target not suitable for BITA grafts in 44 cases (18.9%) and perceived increased risk for sternum complication (ie, osteoporosis) in 38 cases (16.3%). Other causes were hemodynamic instability, which occurred during BITA harvesting in 19 cases (8.1%), intraoperative evidence of other cardiac pathologies requiring intervention in 6 cases (2.6%), and time constraint in 6 cases (2.6%). In 43 cases (18.5%), surgeons decided to not perform BITA grafts without providing a justification (Central Image).
Baseline characteristics in the 2 groups are reported in Table 1 . Overall subjects with intraoperative BITA graft conversion presented a higher-risk profile. In particular, they were more likely to be older and female and were more likely to have diabetes, chronic obstructive pulmonary disease, and left ventricular ejection fraction (LVEF) less than 0.5. Intraoperative data breakdown according to causes of BITA conversion showed that increased body mass index and diabetes were more common among those converted as perceived at higher risk for risk infection, that female gender was more common among those with poor targets, and that reduced LVEF was more common among those with those with hemodynamic instability during ITA harvesting (Table E2 ). After matching, the 2 groups were comparable for all baseline risk factors (all standardized mean difference <0.10) (Figure 2 ). 
Intraoperative Data
Intraoperative data are summarized in Table 2 . Patients who had BITA graft conversion were more likely to be undergo on-pump surgery (23.2% vs 42.1%) and to receive a lower number of grafts (2.95 AE 0.84 vs 3.21 AE 0.74), with left anterior descending (95.3% vs 99.1%) and circumflex (82% vs 95.9%) territories being more likely to remain ungrafted. In the BITA conversion group, 19 patients (8.2%) received SVG only. Intraoperative data breakdown according to causes of BITA conversion showed that the number of grafts was lower among those found to have poor targets (2.52 AE 0.90), and the rate of patients receiving SVG only was higher among those with unsuitable ITAs (18.2%) or hemodynamic instability during harvesting (15.8%) (Table E3) .
Outcomes
Hospital outcomes are summarized in Table 3 . Overall, patients requiring BITA graft conversion were not associated with a higher incidence of hospital morbidity or mortality. In particular, no patient requiring BITA graft conversion experienced hospital death, and the need for IABP and need for repeat revascularization were comparable between the 2 groups. Hospital breakdown FIGURE 2. Changes in standardized mean after matching. LVEF, Left ventricular ejection fraction; COPD, chronic obstructive pulmonary disease; LMSD, left main stem disease; BMI, body mass index; MI, myocardial infarction; NYHA, New York Heart Association; UA, unstable angina; PTCA, percutaneous transcatheter coronary angioplasty; AF, atrial fibrillation; CVA, cerebrovascular accident; PVD, peripheral vascular disease; DBP, diastolic blood pressure; TIA, transient ischemic attack; SBP, systolic blood pressure; SMD, standardized mean difference.
according to causes of BITA conversion showed that those requiring conversion for hemodynamic instability during ITA harvesting presented the highest rate of IABP insertion, renal replacement therapy, and postoperative MI (Table E4) .
Five-year outcomes are summarized in Table 4 and Figure 3 . In patients requiring conversion, we found a nonsignificant excess of deaths (11.9% vs 8.4%; P ¼ .1) and MACCE (17.1% 13.2%; P ¼ .1), mainly driven by an excess of revascularization (Figure 4) . Those who 
PSM, Propensity score matching; LAD, left anterior descending artery; RCA, right coronary artery; SD, standard deviation; BITA, bilateral internal thoracic artery; RA, radial artery; LITA, left internal thoracic artery; RITA, right internal thoracic artery; SVG, saphenous vein graft. required conversion for hemodynamic instability during ITA harvesting and found to have a poor target or unsuitable ITA tended to have a higher rate of mortality and MACCE (Table E4) .
Conduit Selection in Patients Initially Allocated to Single Internal Thoracic Artery
For descriptive purpose, we also reported conduit selection in those initially allocated to SITA grafting. Among 
DISCUSSION
Reasons for the underuse of BITA grafting are uncertain. 4, 5 Many surgeons just do not perform BITA grafts in view of the increased risk of sternal wound 10 and technical complexity. 4 However, the incidence of intraoperative BITA graft conversion to other graft strategies in patients initially intended to receive BITA grafts remains unknown. 7 The perceived increased risk of operative morbidity related to intraoperative conversion can partially contribute to the reluctance of many surgeons to perform BITA grafts in view of the current intense professional and public scrutiny of cardiac surgeons. The ART represents a unique opportunity to investigate the incidence and causes of intraoperative BITA graft conversion. 7 Of note, although participating surgeons were anticipated to be expert in BITA grafts, the rate of intraoperative conversion was not infrequent. In fact, 15.3% of patients initially intended to received BITA grafts required intraoperative conversion to other conduit strategies. However, we noticed that there was a large variation in BITA grafting conversion across surgeons, which supports the central role for individual surgeon experience. Of note, an unsuitable ITA was reported as the main reason (33%) for intraoperative BITA graft conversion to other conduit strategies, and it was mainly related to injury during harvesting. Of note, the rate of an unsuitable ITA in those allocated to SITA grafts was only 0.6%, suggesting that harvesting 2 ITAs is more demanding and can influence a surgeon's precision. In 44 patients, BITA was not performed because of a poor target. Among those patients, only 7 required only 1 graft. In all other cases, the SVG and radial artery were used in addition to SITA grafts, suggesting the technical difficulty of performing BITA grafts rather than the absence of graftable targets. We also found that 19 patients become unstable during BITA harvesting, and we can hypothesis that prolonged heart compression secondary to the use of the chest retractor during ITA harvesting may not always be tolerated, especially in the presence of reduced LVEF. On the other hand, a main reason for conversion not related to complication or technical complexity was the perception of increased risk of sternal wound complication after chest opening (ie, osteoporotic sternum). In case of intraoperative conversion, SITA plus SVG was the most commonly used strategy, followed by SITA plus radial artery. Of note, 19 patients (8.2%) received SVG only.
In contrast to other clinical scenarios where intraoperative conversion significantly increases operative morbidity and mortality, such as off-pump to on-pump conversion, 11 BITA graft conversion was not associated with a significantly higher rate of operative complications, although those requiring conversion for hemodynamic instability during ITA harvesting presented a numerically higher rate of IABP insertion, renal replacement therapy, and postoperative MI. At 5 years, we found a nonsignificant trend toward an excess of death and MACCE in patients requiring intraoperative conversion, in particular among those with perioperative hemodynamic instability, a poor target, and unsuitable ITA. We can speculate that perioperative myocardial injury, a lower number of grafts, and excess of an SVG only strategy in these 3 groups, respectively, might have partially contributed to this trend.
The unique technical challenges of BITA grafts fuels the perception that adoption of this myocardial revascularization strategy may increase operative morbidity, particularly when intraoperative conversion to other conduit strategies is required. The present results support the hypothesis that BITA conversion does not significantly increase operative morbidity. However, the large variation in BITA conversion and its potential implication on late outcomes highlight the importance of negotiating the learning curve with appropriate patient selection, individualized grafting strategy, peer-to-peer training of the entire team, and graded clinical experience.
Study Limitations
There are 2 main limitations in the present analysis. This is a retrospective analysis of the ART, and we cannot exclude residual confounding factors between the 2 groups despite PS adjustment. The number of patients requiring conversion was relatively small, and there was a relatively low incidence of adverse events. Therefore, the analysis was likely to be underpowered to detect significant difference between groups for comparisons. Finally, we had no information whether BITA injury during harvesting occurred with the skeletonized or pedicled technique.
CONCLUSIONS
The incidence of intraoperative BITA graft conversion is not infrequent among experienced surgeons participating in the ART. Although intraoperative BITA graft conversion does not increase the risk of operative mortality and major complications, BITA conversion might be associated with poorer outcomes on long-term follow-up. This requires further investigation.
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